Caffeoylquinic acid derivative and application of caffeoylquinic acid derivative as medicine for repairing and protecting neurons
A technology of caffeoylquinic acid and derivatives, applied in the field of biopharmaceuticals, can solve problems such as unreported, and achieve the effect of significant neuron repair and protection activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Example 1: Preparation of caffeoylquinic acid derivatives A and B.
[0031] 10.0 kg of burdock root medicinal material, soaked in 8-20 times the mass percentage of 55% ethanol aqueous solution overnight, heated and refluxed for 3 times, the first time for 2 hours, and the last two times for 1 hour. The extracts were combined, and the solvent was recovered under reduced pressure to obtain a concentrated extract. The extract was dispersed in appropriate amount of water, and extracted with petroleum ether, dichloromethane, ethyl acetate and n-butanol successively. The solvent was recovered under reduced pressure to obtain petroleum ether extract (15.6 g), dichloromethane extract (43.1 g), ethyl acetate extract (256.8 g) and n-butanol extract (843.2 g). After testing, the ethyl acetate layer had the best activity. The ethyl acetate extract (256.8 g) was passed through a silica gel column, and eluted with dichloromethane-methanol (100:1-1:100) to obtain 15 fractions. Frac...
Embodiment 2
[0034] Example 2: Study on the repair and protection activity of caffeoylquinic acid derivatives on nerve cells in vitro.
[0035] The present invention adopts MTT and LDH activity test methods to measure the protective effect of caffeoylquinic acid derivatives on SH-SY5Y cell damage mediated by hydrogen peroxide, and the results show that caffeoylquinic acid derivatives have a significant effect of repairing nerve cells , so it can be used in the research and development of drugs for the treatment of neurodegenerative diseases, stroke and traumatic brain injury.
[0036] (1) Instruments and reagents: DMEM medium was purchased from Hyclone Company, and fetal bovine serum was Hyclone product; CKX31 inverted microscope (Olympus, Japan); constant temperature CO2 incubator (Thermo, USA); 5810R desktop high-speed and low-temperature Centrifuge (Eppendorf, Germany); Fully automatic microplate reader (Biotek Group, USA); Hydrogen peroxide (Sinopharm Chemical Reagent Co., Ltd.); LDH k...
Embodiment 3
[0045] Embodiment 3: the preparation of pharmaceutical composition
[0046] Compound A 6.5g
[0047] Dextrin 80g
[0048] According to a conventional method, after the above-mentioned substances are mixed uniformly, 1000 equal parts are respectively packed into ordinary gelatin capsules to obtain 1000 capsules.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


